{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:39:23Z","timestamp":1794883163467,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Win Medica SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-specific acute low back pain (LBP) is a common health problem that may be accompanied by muscle spasm and decreased mobility. The combination of non-steroidal anti-inflammatory drugs and muscle relaxants represents an advantageous therapeutic option, however, available data on their combined use are conflicting.<\/jats:p>\n                    <jats:p>This prospective, randomized, single-blind, two-parallel-group trial assessed the efficacy of a single intramuscular (IM) injection of the fixed-dose combination (FDC) diclofenac (75\u00a0mg)-thiocolchicoside (4\u00a0mg\/4\u00a0ml) product (test treatment) compared to diclofenac (75\u00a0mg\/3\u00a0ml) alone (reference treatment) for the symptomatic relief of acute LBP. Tolerability and safety were also assessed as secondary variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>One hundred thirty-four patients were enrolled (safety population) and randomly allocated to the combination or single-agent regimen. Pain intensity and muscle spasm, assessed respectively by the patient-reported visual analogue scale and investigator-performed finger-to-floor distance test, were determined prior to the injection as well as 1 and 3\u00a0h post-injection in 123 patients (per-protocol population). The patients were blinded to treatment. Safety was assessed up to 24\u00a0h post-injection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The test treatment was superior in both alleviating the pain intensity and reducing the finger-to-floor distance at both 1 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023 respectively) and 3\u00a0h post-injection (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). A higher percentage of patients experienced\u2009&gt;\u200930% reduction in pain intensity at 1 and 3\u00a0h with the test treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01 respectively). The corresponding VAS (SD) scores for the test treatment group were at baseline, 1 and 3\u00a0h post-injection 72.03 (\u00b1\u200911.72), 45.37 (\u00b1\u200916.28) and 31.56 (\u00b1\u200915.08) respectively and for the reference treatment group 65.20 (\u00b1\u200912.16), 48.98 (\u00b1\u200918.76) and 44.52 (\u00b1\u200917.33) respectively. No adverse effects were reported with the combination treatment, whereas two patients treated with diclofenac reported dizziness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The FDC treatment is an effective and well-tolerated option for the symptomatic treatment of LBP. Clinical and patient-reported assessments confirmed that a single IM injection of FDC diclofenac-thiocolchicoside was more effective than diclofenac alone in conferring rapid and sustained improvement in mobility and pain intensity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      EudraCT No: 2017\u2013004530-29 Available at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/eudract.ema.europa.eu\/\">https:\/\/eudract.ema.europa.eu\/<\/jats:ext-link>\n                      Registered 04 Dec 2017.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-023-06599-0","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T08:01:42Z","timestamp":1686384102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A randomized controlled trial evaluating the short-term efficacy of a single-administration intramuscular injection with the fixed combination of thiocolchicoside-diclofenac versus diclofenac monotherapy in patients with acute moderate-to-severe low back pain"],"prefix":"10.1186","volume":"24","author":[{"given":"Konstantinos","family":"Iliopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Koufaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Tsilikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriakos","family":"Avramidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Tsagkalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Zintzaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,10]]},"reference":[{"issue":"6","key":"6599_CR1","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/art.34347","volume":"64","author":"D Hoy","year":"2012","unstructured":"Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64(6):2028\u201337.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"6599_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/annrheumdis-2013-204428","volume":"73","author":"D Hoy","year":"2014","unstructured":"Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968\u201374.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6599_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2474-15-50","volume":"15","author":"R Froud","year":"2014","unstructured":"Froud R, Patterson S, Eldridge S, Seale C, Pincus T, Rajendran D, et al. A systematic review and meta-synthesis of the impact of low back pain on people\u2019s lives. BMC Musculoskelet Disord. 2014;15(1):50.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"6599_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.spinee.2014.06.018","volume":"15","author":"DJ Schofield","year":"2015","unstructured":"Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Kelly SJ, Percival R. Back problems, comorbidities, and their association with wealth. Spine J. 2015;15(1):34\u201341.","journal-title":"Spine J"},{"issue":"7555","key":"6599_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/bmj.332.7555.1430","volume":"332","author":"BW Koes","year":"2006","unstructured":"Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332(7555):1430\u20134.","journal-title":"BMJ"},{"issue":"3","key":"6599_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/acr.22533","volume":"67","author":"D Steffens","year":"2015","unstructured":"Steffens D, Ferreira ML, Latimer J, Ferreira PH, Koes BW, Blyth F, et al. What triggers an episode of acute low back pain? A case-crossover study. Arthritis Care Res. 2015;67(3):403\u201310.","journal-title":"Arthritis Care Res"},{"key":"6599_CR7","unstructured":"Lower Back Pain Symptoms, Diagnosis, and Treatment [Internet]. 2017 [cited March 2021]. Available from: https:\/\/www.spine-health.com\/conditions\/lower-back-pain\/lower-back-pain-symptoms-diagnosis-and-treatment."},{"issue":"7410","key":"6599_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/bmj.327.7410.323","volume":"327","author":"LH Pengel","year":"2003","unstructured":"Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute low back pain: systematic review of its prognosis. BMJ. 2003;327(7410):323.","journal-title":"BMJ"},{"issue":"Suppl 4","key":"6599_CR9","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1111\/j.1526-4637.2011.01253.x","volume":"12","author":"BH McCarberg","year":"2011","unstructured":"McCarberg BH, Ruoff GE, Tenzer-Iglesias P, Weil AJ. Diagnosis and treatment of low-back pain because of paraspinous muscle spasm: a physician roundtable. Pain Med (Malden, Mass). 2011;12(Suppl 4):S119\u201327.","journal-title":"Pain Med (Malden, Mass)"},{"issue":"2","key":"6599_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0268-0033(86)90085-9","volume":"1","author":"MO Roland","year":"1986","unstructured":"Roland MO. A critical review of the evidence for a pain-spasm-pain cycle in spinal disorders. Clin Biomech (Bristol, Avon). 1986;1(2):102\u20139.","journal-title":"Clin Biomech (Bristol, Avon)"},{"key":"6599_CR11","first-page":"579","volume":"5","author":"L Kuritzky","year":"2012","unstructured":"Kuritzky L, Samraj GP. Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. J Pain Res. 2012;5:579\u201390.","journal-title":"J Pain Res"},{"issue":"2","key":"6599_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/17512433.2019.1565992","volume":"12","author":"M Schreijenberg","year":"2019","unstructured":"Schreijenberg M, Koes BW, Lin CC. Guideline recommendations on the pharmacological management of non-specific low back pain in primary care - is there a need to change? Expert Rev Clin Pharmacol. 2019;12(2):145\u201357.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6599_CR13","doi-asserted-by":"crossref","unstructured":"van der Gaag WH, Roelofs PD, Enthoven WT, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for acute low back pain. Cochrane Database Syst Rev. 2020;4(4):Cd013581.","DOI":"10.1002\/14651858.CD013581"},{"issue":"2","key":"6599_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejp.907","volume":"21","author":"C Abdel Shaheed","year":"2017","unstructured":"Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain. 2017;21(2):228\u201337.","journal-title":"Eur J Pain"},{"key":"6599_CR15","doi-asserted-by":"crossref","unstructured":"Cashin AG, Folly T, Bagg MK, Wewege MA, Jones MD, Ferraro MC, et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis. BMJ. 2021;374:n1446-n.","DOI":"10.1136\/bmj.n1446"},{"key":"6599_CR16","doi-asserted-by":"crossref","unstructured":"van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low back pain. The Cochrane database of systematic reviews. 2003;2003(2):Cd004252.","DOI":"10.1002\/14651858.CD004252"},{"issue":"2","key":"6599_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s101950200036","volume":"3","author":"C Aksoy","year":"2002","unstructured":"Aksoy C, Karan A, D\u0131ra\u00e7o\u011flu D. Low back pain: results of an open clinical trial comparing the standard treatment alone to the combination of standard treatment and thiocolchicoside. J Orthop Traumatol. 2002;3(2):103\u20138.","journal-title":"J Orthop Traumatol"},{"issue":"2","key":"6599_CR18","first-page":"125","volume":"12","author":"DG Borenstein","year":"1990","unstructured":"Borenstein DG, Lacks S, Wiesel SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther. 1990;12(2):125\u201331.","journal-title":"Clin Ther"},{"key":"6599_CR19","first-page":"93","volume":"28","author":"N Akhter","year":"2017","unstructured":"Akhter N, Siddiq MZ. Comparative efficacy of diclofenac sodium alone and in combination with thiocolchicoside in patients with low back pain. Med Forum. 2017;28:93\u20136.","journal-title":"Med Forum"},{"key":"6599_CR20","first-page":"1927","volume":"9","author":"P Aparna","year":"2016","unstructured":"Aparna P, Geetha P, Shanmugasundaram P. Comparison of aceclofenac and combination (Aceclofenac + thiocolchicoside) therapy in acute low back pain patients. CRes J Pharm Technol. 2016;9:1927\u20139.","journal-title":"CRes J Pharm Technol"},{"issue":"1","key":"6599_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40122-019-0112-6","volume":"8","author":"HD Patel","year":"2019","unstructured":"Patel HD, Uppin RB, Naidu AR, Rao YR, Khandarkar S, Garg A. Efficacy and Safety of Combination of NSAIDs and Muscle Relaxants in the Management of Acute Low Back Pain. Pain Ther. 2019;8(1):121\u201332.","journal-title":"Pain Ther"},{"key":"6599_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/DHPS.S278467","volume":"12","author":"RT Pinzon","year":"2020","unstructured":"Pinzon RT, Wijaya VO, Paramitha D, Bagaskara RR. Effects of Eperisone Hydrochloride and Non-Steroid Anti-Inflammatory Drugs (NSAIDs) for Acute Non-Specific Back Pain with Muscle Spasm: A Prospective, Open-Label Study. Drug Healthc Patient Saf. 2020;12:221\u20138.","journal-title":"Drug Healthc Patient Saf"},{"issue":"3","key":"6599_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.annemergmed.2017.09.031","volume":"71","author":"BW Friedman","year":"2018","unstructured":"Friedman BW, Cisewski D, Irizarry E, Davitt M, Solorzano C, Nassery A, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain. Ann Emerg Med. 2018;71(3):348-56.e5.","journal-title":"Ann Emerg Med"},{"issue":"15","key":"6599_CR24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1001\/jama.2015.13043","volume":"314","author":"BW Friedman","year":"2015","unstructured":"Friedman BW, Dym AA, Davitt M, Holden L, Solorzano C, Esses D, et al. Naproxen With Cyclobenzaprine, Oxycodone\/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Clinical Trial. JAMA. 2015;314(15):1572\u201380.","journal-title":"JAMA"},{"issue":"4","key":"6599_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.annemergmed.2019.02.017","volume":"74","author":"BW Friedman","year":"2019","unstructured":"Friedman BW, Irizarry E, Solorzano C, Zias E, Pearlman S, Wollowitz A, et al. A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain. Ann Emerg Med. 2019;74(4):512\u201320.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"6599_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.23736\/S1973-9087.17.04923-1","volume":"54","author":"E Sproviero","year":"2018","unstructured":"Sproviero E, Albamonte E, Costantino C, Giossi A, Mancuso M, Rigamonti A, et al. Efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg in the treatment of acute low back pain: a phase III, randomized, double blind, controlled trial. Eur J Phys Rehabil Med. 2018;54(5):654\u201362.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"2","key":"6599_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4184\/asj.2012.6.2.115","volume":"6","author":"R Rao","year":"2012","unstructured":"Rao R, Panghate A, Chandanwale A, Sardar I, Ghosh M, Roy M, et al. Clinical comparative study: efficacy and tolerability of tolperisone and thiocolchicoside in acute low back pain and spinal muscle spasticity. Asian Spine J. 2012;6(2):115\u201322.","journal-title":"Asian Spine J"},{"issue":"5","key":"6599_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S1297-319X(03)00075-7","volume":"70","author":"F T\u00fcz\u00fcn","year":"2003","unstructured":"T\u00fcz\u00fcn F, Unalan H, Oner N, Ozg\u00fczel H, Kirazli Y, I\u00e7a\u011fasio\u011flu A, et al. Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain. Joint Bone Spine. 2003;70(5):356\u201361.","journal-title":"Joint Bone Spine"},{"key":"6599_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/102490790401100202","volume":"11","author":"MK Ho","year":"2004","unstructured":"Ho MK, Chung CH. A Prospective, Randomised Clinical Trial Comparing Oral Diclofenac Potassium and Intramuscular Diclofenac Sodium in Acute Pain Relief. Hong Kong J Emerg Med. 2004;11:69\u201377.","journal-title":"Hong Kong J Emerg Med"},{"issue":"8","key":"6599_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2165\/00044011-200727080-00002","volume":"27","author":"H Zippel","year":"2007","unstructured":"Zippel H, Wagenitz A. A multicentre, randomised, double-blind study comparing the efficacy and tolerability of intramuscular dexketoprofen versus diclofenac in the symptomatic treatment of acute low back pain. Clin Drug Investig. 2007;27(8):533\u201343.","journal-title":"Clin Drug Investig"},{"key":"6599_CR31","unstructured":"Summary of product's characteristics: Voltarol\u00ae Ampoules (diclofenac sodium). [Internet]. Novartis Pharmaceuticals UK Limited. 2021. Available from: https:\/\/www.medicines.org.uk\/emc\/medicine\/1339#gref.\u00a0Accessed 16 May 2023."},{"issue":"1","key":"6599_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/BRS.0b013e31815e3a10","volume":"33","author":"RW Ostelo","year":"2008","unstructured":"Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, et al. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine. 2008;33(1):90\u20134.","journal-title":"Spine"},{"issue":"1","key":"6599_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0149-2918(02)85007-X","volume":"24","author":"M Palangio","year":"2002","unstructured":"Palangio M, Morris E, Doyle RT Jr, Dornseif BE, Valente TJ. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain. Clin Ther. 2002;24(1):87\u201399.","journal-title":"Clin Ther"},{"issue":"2","key":"6599_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.21037\/qims.2016.04.06","volume":"6","author":"YXJ W\u00e1ng","year":"2016","unstructured":"W\u00e1ng YXJ, W\u00e1ng J-Q, K\u00e1pl\u00e1r Z. Increased low back pain prevalence in females than in males after menopause age: evidences based on synthetic literature review. Quant Imaging Med Surg. 2016;6(2):199\u2013206.","journal-title":"Quant Imaging Med Surg"},{"key":"6599_CR35","unstructured":"Bardot, A., Caniot D., Chabert JL. The efficacy of thiocolchicoside in the treatment of acute paravertebral muscle contractures. Letter Rheumatol. 1984;31 (Suppl.):4\u20139."},{"issue":"10","key":"6599_CR36","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1080\/03007995.2020.1814228","volume":"36","author":"S Meloncelli","year":"2020","unstructured":"Meloncelli S, Divizia M, Germani G. Efficacy and tolerability of orally administered tramadol\/dexketoprofen fixed-dose combination compared to diclofenac\/thiocolchicoside in acute low back pain: experience from an Italian, single-centre, observational study. Curr Med Res Opin. 2020;36(10):1687\u201393.","journal-title":"Curr Med Res Opin"},{"key":"6599_CR37","doi-asserted-by":"crossref","unstructured":"Roberts C, Torgerson DJ. Understanding controlled trials: baseline imbalance in randomised controlled trials. BMJ. 1999;319(7203):185.","DOI":"10.1136\/bmj.319.7203.185"},{"issue":"3","key":"6599_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jpain.2018.07.009","volume":"20","author":"A Chiarotto","year":"2019","unstructured":"Chiarotto A, Maxwell LJ, Ostelo RW, Boers M, Tugwell P, Terwee CB. Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review. J Pain. 2019;20(3):245\u201363.","journal-title":"J Pain"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06599-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-06599-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06599-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T08:02:15Z","timestamp":1686384135000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-06599-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6599"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-06599-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,10]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained before recruitment, and ethics approval for the study was granted by the Greek National Ethics Committee and the National Organization for Medicines. This trial was registered with EudraCT No: 2017\u2013004530-29.This trial was performed in accordance with the ethical standards of the Declaration of Helsinki. The participants were blinded to the treatment they received.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EZ is contracted in the Clinical Research Organization that monitored the study. PK is an employee of the company that sponsored the study. KI, ST, KA, AT and CM were investigators in the hospitals where the study was conducted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}